HuGE Literature Finder
Records
1
-
30
| EGFR Mutation-Positive Unresectable Stage III Non-Squamous Lung Cancer is Associated with a High Incidence of Brain Metastasis. Cancer research and treatment 2022 Oct . Kim Hongsik, Park Sehhoon, Jung Hyun Ae, Sun Jong-Mu, Lee Se-Hoon, Ahn Jin Seok, Ahn Myung- |
| Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer. FEBS open bio 2022 Oct . Xu Fei, Cui Wen-Qiang, Liu Cun, Feng Fubin, Liu Ruijuan, Zhang Jingtao, Sun Chang-Ga |
| Adjuvant chemotherapy in patients with recurrence after completely resected stage IB lung adenocarcinoma: Propensity-matched analysis in a cohort of 147 recurrences. Thoracic cancer 2022 Sep . Xu Fei, Chen Heng-Chi, Xu Haiyan, Li Junling, Hao Xuezhi, Xing Puyuan, Ying Jianming, Wang Y |
| Biological difference between L858R and exon 19 deletion contributes to recurrence-free survival of resected non-small cell lung cancer. Oncology 2022 Sep . Masago Katsuhiro, Kuroda Hiroaki, Fujita Shiro, Sasaki Eiichi, Takahashi Yusuke, Shinohara Shuichi, Matsushita Hiroka |
| EGFR mutation prevalence, real-world treatment patterns, and outcomes among patients with resected, early-stage, non-small cell lung cancer in Canada. Lung cancer (Amsterdam, Netherlands) 2022 Sep 173 58-66. Sara Kuruvilla M, Liu Geoffrey, Syed Iqra, Gwadry-Sridhar Femida, Sheffield Brandon S, Sachdeva Robin, Pencz Alec, Zhan Luna, Hueniken Katrina, Patel Devalben, Balaratnam Karmugi, Khan Khaleeq, Grant Benjamin, Noy Shawna, Singh Karan, Liu Linda, Rakibuz-Zaman Muhammad, Moldaver Daniel, Kate Shanahan Mary, Cheema Parneet |
| Advances in the treatment of postoperative recurrence of non-small cell lung cancer and their impact on survival in Asian patients. The Journal of thoracic and cardiovascular surgery 2022 Aug . Hashimoto Kohei, Ariyasu Ryo, Ichinose Junji, Matsuura Yosuke, Nakao Masayuki, Amino Yoshiaki, Uchibori Ken, Kitazono Satoru, Yanagitani Noriko, Okumura Sakae, Nishio Makoto, Mun Mingy |
| The prognostic impact of lung adenocarcinoma predominance classification relating to pathological factors in lobectomy, the Japanese Joint Committee of Lung Cancer Registry Database in 2010. BMC cancer 2022 Aug 22 (1): 875. Ito Hiroyuki, Date Hiroshi, Shintani Yasushi, Miyaoka Etsuo, Nakanishi Ryoichi, Kadokura Mitsutaka, Endo Shunsuke, Chida Masayuki, Yoshino Ichiro, Suzuki Hidemi, |
| Prognostic factors in completely resected lymph-node-negative pulmonary adenocarcinoma. Translational cancer research 2022 Jul 11 (7): 2238-2248. Pakvisal Nussara, Chantranuwat Poonchavist, Vinayanuwattikun Chanida, Sitthideatphaiboon Piyada, Teerapakpinyo Chinachote, Shuangshoti Shanop, Benjacholamas Vichai, Pornpattanarak Nopporn, Sriuranpong Viro |
| Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancer. BMC cancer 2022 Jul 22 (1): 775. Matsumoto Yoshiya, Kawaguchi Tomoya, Watanabe Masaru, Isa Shun-Ichi, Ando Masahiko, Tamiya Akihiro, Kubo Akihito, Kitagawa Chiyoe, Yoshimoto Naoki, Koh Yasuhi |
| Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis. Pathology 2022 Jun . Tsang Julia Y, Shao Yan, Poon Ivan K, Ni Yun-Bi, Kwan Johnny S, Chow Chit, Shea Ka-Ho, Tse Gary |
| Distribution and favorable prognostic implication of genomic EGFR alterations in IDH-wildtype glioblastoma. Cancer medicine 2022 Jun . Higa Nayuta, Akahane Toshiaki, Hamada Taiji, Yonezawa Hajime, Uchida Hiroyuki, Makino Ryutaro, Watanabe Shoji, Takajo Tomoko, Yokoyama Seiya, Kirishima Mari, Matsuo Kei, Fujio Shingo, Hanaya Ryosuke, Tanimoto Akihide, Yoshimoto Ko |
| Survival benefit of using pemetrexed for EGFR mutation-positive advanced non-small-cell lung cancer in a randomized phase III study comparing gefitinib to cisplatin plus docetaxel (WJTOG3405). International journal of clinical oncology 2022 Jun . Haratake Naoki, Shimokawa Mototsugu, Seto Takashi, Yoshioka Hiroshige, Yamamoto Nobuyuki, Nakagawa Kazuhiko, Mitsudomi Tetsu |
| Cytoplasmic expression of G protein-coupled estrogen receptor 1 correlates with poor postoperative prognosis in non-small cell lung cancer. Journal of thoracic disease 2022 May 14 (5): 1466-1477. Li Zhen-Hua, Liu Chang, Liu Qing-Hua, Wang Jian, Wang Ying, Wang Yan-Fei, Deng Shou-Jun, Li Ding-Bi |
| Impact of genetic status on the survival outcomes of patients with clinical stage I non-small cell lung cancer with a radiological pure-solid appearance. Lung cancer (Amsterdam, Netherlands) 2022 Feb 166 63-69. Sun Ke, Li Meiling, Shang Mingdong, Su Xiaolian, Zhao Jiabi, Wang Bin, Wu Chunyan, Zhang Lei, Yang Shan, Sun Xiw |
| A prediction model integrated genomic alterations and immune signatures of tumor immune microenvironment for early recurrence of stage I NSCLC after curative resection. Translational lung cancer research 2022 Jan 11 (1): 24-42. Hu Chunhong, Shu Long, Chen Chen, Fan Songqing, Liang Qingchun, Zheng Hongmei, Pan Yue, Zhao Lishu, Zou Fangwen, Liu Chaoyuan, Liu Wenliang, Yu Feng-Lei, Liu Xianling, Liu Lijuan, Yang Lingling, Shao Yang, Wu Fa |
| Machine learning-based algorithm demonstrates differences in del19 and L858R EGFR subgroups in non-small cell lung cancer: a single center experience. American journal of translational research 2022 14 (4): 2677-2684. Batra Ullas, Nathany Shrinidhi, Sharma Mansi, Mehta Anurag, Dhanda Surender, Jose Joslia |
| Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors as a first-line treatment for postoperative recurrent and EGFR-mutated non-small-cell lung cancer. Interactive cardiovascular and thoracic surgery 2021 Oct . Moriya Tetsuji, Hamaji Masatsugu, Yoshizawa Akihiko, Miyata Ryo, Noguchi Misa, Tamari Shigeyuki, Chiba Naohisa, Miyamoto Hideaki, Toyazaki Toshiya, Tanaka Satona, Yamada Yoshito, Yutaka Yojiro, Nakajima Daisuke, Ohsumi Akihiro, Menju Toshi, Date Hiros |
| Frequent EGFR Mutations and Better Prognosis in Positron Emission Tomography-Negative, Solid-Type Lung Cancer. Clinical lung cancer 2021 Oct . Suda Kenichi, Ohara Shuta, Fujino Toshio, Hamada Akira, Chiba Masato, Shimoji Masaki, Takemoto Toshiki, Soh Junichi, Mitsudomi Tetsu |
| Thioredoxin reductase-1 levels are associated with NRF2 pathway activation and tumor recurrence in non-small cell lung cancer. Free radical biology & medicine 2021 Oct 177 58-71. Delgobo Marina, Gonçalves Rosângela Mayer, Delazeri Marco Antônio, Falchetti Marcelo, Zandoná Alessandro, Nascimento das Neves Raquel, Almeida Karoline, Fagundes Adriane Cristina, Gelain Daniel Pens, Fracasso João Isidro, Macêdo Guilherme Baroni de, Priori Leonardo, Bassani Nicklas, Bishop Alexander James Roy, Forcelini Cassiano Mateus, Moreira José Cláudio Fonseca, Zanotto-Filho Alf |
| Neutrophil-to-lymphocyte ratio is correlated to driver gene mutations in surgically-resected non-small cell lung cancer and its post-operative evolution impacts outcomes. Clinical lung cancer 2021 Aug . Seitlinger Joseph, Prieto Mathilde, Guerrera Francesco, Streit Arthur, Gauchotte Guillaume, Siat Joelle, Falcoz Pierre-Emmanuel, Massard Gilbert, Ferri Lorenzo, Spicer Jonathan, Renaud Stépha |
| Neurosurgical resection for locally recurrent brain metastasis. Neuro-oncology 2021 Jul . Hulsbergen Alexander F C, Abunimer Abdullah M, Ida Fidelia, Kavouridis Vasileios K, Cho Logan D, Tewarie Ishaan A, Mekary Rania A, Schucht Philippe, Phillips John G, Verhoeff Joost J C, Broekman Marike L D, Smith Timothy |
| Validation of the Novel IASLC Grading System for Invasive Pulmonary Adenocarcinoma and Association with Common Driver Mutations. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 Jul . Deng Chaoqiang, Zheng Qiang, Zhang Yang, Jin Yan, Shen Xuxia, Nie Xiao, Fu Fangqiu, Ma Xiangyi, Ma Zelin, Wen Zhexu, Wang Shengping, Li Yuan, Chen Haiqu |
| Dynamics of circulating tumor DNA during postoperative radiotherapy in patients with residual triple-negative breast cancer following neoadjuvant chemotherapy: a prospective observational study. Breast cancer research and treatment 2021 Jun . Kim Haeyoung, Kim Yeon Jeong, Park Donghyun, Park Woong-Yang, Choi Doo Ho, Park Won, Cho Won Kyung, Kim Nal |
| Integration of clinicopathological and mutational data offers insight into lung cancer with tumor spread through air spaces. Annals of translational medicine 2021 Jun 9 (12): 985. Tian Yu, Feng Jing, Jiang Long, Ning Junwei, Gu Zenan, Huang Jia, Luo Qingqu |
| Course of renal allograft function after diagnosis and treatment of post-transplant lymphoproliferative disorders in pediatric kidney transplant recipients. Pediatric transplantation 2021 May e14042. Zierhut Henriette, Kanzelmeyer Nele, Buescher Anja, Höcker Britta, Mauz-Körholz Christine, Tönshoff Burkhard, Metzler Markus, Pohl Martin, Pape Lars, Maecker-Kolhoff Brit |
| Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung. Journal of cancer research and clinical oncology 2021 Apr . Ueda Daisuke, Ito Masaoki, Tsutani Yasuhiro, Giménez-Capitán Ana, Román-Lladó Ruth, Pérez-Rosado Ana, Aguado Cristina, Kushitani Kei, Miyata Yoshihiro, Arihiro Koji, Molina-Vila Miguel Angel, Rosell Rafael, Takeshima Yukio, Okada Morihi |
| Preoperative nivolumab to evaluate pathological response in patients with stage I non-small cell lung cancer: a study protocol of phase II trial (POTENTIAL). BMJ open 2021 (3): e043234. Kagimoto Atsushi, Tsutani Yasuhiro, Mimae Takahiro, Miyata Yoshihiro, Ikeda Norihiko, Ito Hiroyuki, Maniwa Yoshimasa, Suzuki Kenji, Tsuboi Masahiro, Yoshimura Kenichi, Umemoto Seiji, Okada Morihi |
| Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 Feb . Aredo Jacqueline V, Mambetsariev Isa, Hellyer Jessica A, Amini Arya, Neal Joel W, Padda Sukhmani K, McCoach Caroline E, Riess Jonathan W, Cabebe Elwyn C, Naidoo Jarushka, Abuali Tariq, Salgia Ravi, Loo Billy W, Diehn Maximilian, Han Summer S, Wakelee Heather |
| Adjuvant EGFR-TKIs for Patients With Resected EGFR-Mutant Non-Small Cell Lung Cancer: A Meta-Analysis of 1,283 Patients. Frontiers in oncology 2021 11 629394. Chen Rui-Lian, Sun Ling-Ling, Cao Yang, Chen Han-Rui, Zhou Jing-Xu, Gu Chu-Ying, Zhang Ying, Wang Si-Yu, Hou Wei, Lin Li-Z |
| Genomic Profiling and Prognostic Value Analysis of Genetic Alterations in Chinese Resected Lung Cancer With Invasive Mucinous Adenocarcinoma. Frontiers in oncology 2020 10 603671. Cai Lei, Wang Jiangfeng, Yan Junrong, Zeng Jian, Zhu Liang, Liang Jinxiao, Pan Chao, Huang Xiancong, Jin Ju, Xu Yang, Wang Fufeng, Shao Yang, Xu Qinqin, Xia Guojie, Xing Minyan, Xu Xiaoling, Jiang Youh |
- Page last reviewed:Jul 25, 2022
- Page last updated:Dec 05, 2022
- Content source: